Evidence map›Paper›PMID 38191431›Full record

ArticleRadiation oncology (London, England)2024

Comparison of deep learning networks for fully automated head and neck tumor delineation on multi-centric PET/CT images.

Yiling Wang, Elia Lombardo, Lili Huang, Michele Avanzo, Giuseppe Fanetti, Giovanni Franchin, Sebastian Zschaeck, Julian Weingärtner, Claus Belka, Marco Riboldi and 2 more

Abstract read
In one paragraph

Article in Radiation oncology (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Molecular Imaging in Photon Radiotherapy.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2026
    Review
  6. Article
  7. Article
  8. Gradient Map-Assisted Head and Neck Tumor Segmentation: A Pre-RT to Mid-RT Approach in MRI-Guided Radiotherapy.Head and Neck Tumor Segmentation for MR-Guided Applications : First MICCAI Challenge, HNTS-MRG 2024, held in conjunction with MICCAI 2024, Marrakesh, Morocco, October 17, 2024, proceedings · 2025
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yiling WangDepartment of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
Elia LombardoDepartment of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
Lili HuangDepartment of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
Michele AvanzoCentro di Riferimento Oncologico di Aviano (CRO) IRCCS, Medical Physics, Aviano, Italy.
Giuseppe FanettiCentro di Riferimento Oncologico di Aviano (CRO) IRCCS, Radiation Oncology, Aviano, Italy.
Giovanni FranchinCentro di Riferimento Oncologico di Aviano (CRO) IRCCS, Radiation Oncology, Aviano, Italy.
Sebastian ZschaeckRadiation Oncology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Berlin, Germany.
Julian WeingärtnerRadiation Oncology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Berlin, Germany.
Claus BelkaDepartment of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
Marco RiboldiDepartment of Medical Physics, Ludwig-Maximilians-Universität München, Garching, Germany.
Christopher Kurz *Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
Guillaume Landry *Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany. guillaume.landry@med.uni-muenchen.de.

Funding

China Postdoctoral Science Foundation 2019M663471Förderprogramm für Forschung und Lehre, Medical Faculty, LMU Munich 1084Fundamental Research Funds for the Central Universities ZYGX2021YGCX008German Research Foundation (DFG), Research Training Group GRK 2274Sichuan Province Science and Technology Support Program 2023YFH0079
6 · The paper itself

Abstract

objectivesDeep learning-based auto-segmentation of head and neck cancer (HNC) tumors is expected to have better reproducibility than manual delineation. Positron emission tomography (PET) and computed tomography (CT) are commonly used in tumor segmentation. However, current methods still face challenges in handling whole-body scans where a manual selection of a bounding box may be required. Moreover, different institutions might still apply different guidelines for tumor delineation. This study aimed at exploring the auto-localization and segmentation of HNC tumors from entire PET/CT scans and investigating the transferability of trained baseline models to external real world cohorts.

methodsWe employed 2D Retina Unet to find HNC tumors from whole-body PET/CT and utilized a regular Unet to segment the union of the tumor and involved lymph nodes. In comparison, 2D/3D Retina Unets were also implemented to localize and segment the same target in an end-to-end manner. The segmentation performance was evaluated via Dice similarity coefficient (DSC) and Hausdorff distance 95th percentile (HD

resultsEncouraging localization results were observed, achieving a maximum omnidirectional tumor center difference lower than 6.8 cm for external testing. The three baseline models yielded similar averaged cross-validation (CV) results with a DSC in a range of 0.71-0.75, while the averaged CV HD

conclusionThe regular Unet outperformed the other two baseline models in CV and most external testing cohorts. Facility-specific transfer learning can potentially improve HNC segmentation performance for individual institutions, where the 2D Retina Unets could achieve comparable or even better results than the regular Unet.

Indexed as

Deep LearningHead and Neck NeoplasmsHumansPositron-Emission TomographyPositron Emission Tomography Computed TomographyReproducibility of ResultsAuto-segmentationFacility-specific transfer learningHead and Neck cancerPET/CTTumor localization

Identifiers

PMID38191431
PMCPMC10773015

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.